$ARIA Headlines Hewlett-Packard, a cyclical green light

New Post Public Reply Private Reply Replies (0) Message Board

Dec 6, 2013 at 9:59 AM

$ARIA Headlines

Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Aria rockets on cancer drug data 9:38 a.m. Jan. 18, 2011 - Val Brickates Kennedy

7 Biotechnology Stocks to Buy Now 6:30 a.m. Dec. 4, 2013 - InvestorPlace.com
3 Best Performing Stocks of November in Focus - Analyst Blog 5:34 p.m. Dec. 2, 2013 - Zacks.com
Today's Pre-Market Trading Very Positive For Ariad Pharmaceuticals (ARIA) 7:52 a.m. Dec. 2, 2013 - TheStreet.com
Biotech Stocks Partying Like It's 1999 7:00 a.m. Dec. 2, 2013 - TheStreet.com
Benzinga's Top #PreMarket Losers 7:19 a.m. Nov. 29, 2013 - benzinga.com
Four Biotech 'Surprise' Stocks for 2014 7:00 a.m. Nov. 27, 2013 - TheStreet.com
5 Biotechnology Stocks to Buy Now 7:00 a.m. Nov. 27, 2013 - InvestorPlace.com
Wednesday’s Biggest Stock Losers: BLOX, BRLI and More 5:10 a.m. Nov. 27, 2013 - InvestorPlace.com
Ariad Pharmaceuticals (ARIA) In A Perilous Reversal 11:50 a.m. Nov. 26, 2013 - TheStreet.com
Nuance and ARIAD Are Volume Movers for Very Different Reasons 11:24 a.m. Nov. 26, 2013 - 247WallSt.com
Ariad Pharma Appears Cheap Despite Reduced Opportunity 9:19 a.m. Nov. 26, 2013 - Seeking Alpha
Cramer's Lightning Round - What Happened With Ariad Was Jarring (11/25/13) 6:05 a.m. Nov. 26, 2013 - Seeking Alpha
'Mad Money' Lightning Round: Buy, Buy, Buy Splunk 6:00 a.m. Nov. 26, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Glass-Half-Full Market 8:25 p.m. Nov. 25, 2013 - TheStreet.com
Continuation of ARIAD's Iclusig in EU - Analyst Blog 5:00 p.m. Nov. 25, 2013 - Zacks.com
Market Wrap For November 25: Nasdaq Breaks 4,000 Level For First Time Since 2000 3:57 p.m. Nov. 25, 2013 - benzinga.com
ARIAD Shares Skyrocketing With 11 Positive Estimate Revisions 1:35 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Why Ariad Pharmaceuticals (ARIA) is Soaring 1:27 p.m. Nov. 25, 2013 - TheStreet.com
Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Barbarian At The Gate" Stock 12:36 p.m. Nov. 25, 2013 - TheStreet.com
3 Monday Morning Biotech Movers 12:15 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet

UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 6:11 p.m. Dec. 5, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 9:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 7:00 a.m. Dec. 5, 2013 - Marketwire
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Ariad Pharmaceuticals, Inc. -- ARIA 6:28 p.m. Dec. 3, 2013 - GlobeNewswire
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 7:35 a.m. Dec. 3, 2013 - BusinessWire
TrendingWallStreet.com Reports Volume Coverage on ZOOM, FARE, BAC, and ARIA 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
ARIA, AAPL, EBAY and CAMT added to NASDAQ Active Stock Watch List at EPR 10:34 a.m. Dec. 2, 2013 - ACCESSWIRE
Traders Buzz: Tesla Motors Inc, Sirius XM Radio, Microsoft Corporation, Ariad Pharmaceuticals 9:35 a.m. Dec. 2, 2013 - ACCESSWIRE
TrendingWallStreet.com Starts Volume Coverage on AAPL, IACH, ARIA, and JCP 12:45 a.m. Dec. 2, 2013 - ACCESSWIRE
Positive Opinion, Program Honorees, Positive Medical Results, and Investor Day - Research Report on Bristol-Myers Squibb, Ariad Pharmaceuticals, Dyax, Ironwood Pharmaceuticals, and Immunomedics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
TrendingWallStreet.com Begins Market Coverage on NLY, VEND, ARIA, and FB 12:15 a.m. Nov. 27, 2013 - ACCESSWIRE
Must Watch Stocks: Ariad Pharmaceuticals, Hewlett-Packard Company, Camtek Ltd, Buka Ventures Inc 9:01 a.m. Nov. 26, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Analysis on BAC, NVGC, ARIA, and C 12:16 a.m. Nov. 26, 2013 - ACCESSWIRE
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:10 a.m. Nov. 25, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Coverage on ARIA, TXCC, SFTBY, and TWC 1:38 a.m. Nov. 25, 2013 - ACCESSWIRE
Law Offices of Howard G. Smith Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. -- ARIA 3:32 p.m. Nov. 22, 2013 - GlobeNewswire
ARIA, MU, AMRN and ARUN added to NASDAQ Active Stock Watch List at EPR 10:19 a.m. Nov. 22, 2013 - ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against ARIAD Pharmaceuticals, Inc. and Certain Officers - ARIA 8:00 a.m. Nov. 22, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PG&E's $500K Grants Wrap Up Five-Year Environmental Push

Wrapping Up a Half-Decay of Environmental Commitment PG&E has been playing the long game with its environmental initiatives, and this wraps up a five-year saga that's worth dissecting. The PG&E Corporation Foundation has doled out its final set of grants, making a 25-strong lineup of eco-friendly campaigns. We're talking $500,000 split among five organizations trying to...

Glance's Guide Bridges AI and Human Service Gaps

Untangling the AI to Human Transition Ever found yourself stuck in a never-ending loop with AI, screaming for a human voice? You're not alone. According to Glance's 2026 Customer Experience Trends Report, a staggering 76% of consumers are pulling their hair out while repeating themselves when switching service channels. The rub? Only 7% claim they rarely experience this...

Gildan Faces Lawsuit: Allegations of Revenue Inflations

Gildan's Revenue Magic Trick or Corporate Roulette? Imagine turning on the news just as Gildan's stock takes a freefall dive. June 16, 2026, didn't just mark another dip on the charts for NYSE: GIL; it sent investors tripping over phone cords as shares plummeted a whopping 18.75%. That's not your everyday market swing, folks. Behind this dramatic drop looms a hefty class...

Neuberger Fund Ups Distribution Amid Market Challenges

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

Chemical Industry Golf Event Raises $100,000 for STEM

Golf Goes Beyond the Green Picture this: industry bigwigs teeing off for a cause that actually matters. We're talking about the Swings for STEM golf tournament, where $100,000 was drummed up for the future minds that'll drive tomorrow's chemical industry. Now, that's what you call putting your money where your mouth is. This wasn't about boasting scores on the links; it...

ServiceTitan Faces Investor Fury: Revenue Surprise

A Crippling Blow for ServiceTitan Investors When you're in the investing game long enough, you start to recognize the scent of trouble before it even hits the fan. In the case of ServiceTitan, Inc. (NASDAQ: TTAN), the smell came wafting in strong when the stock took a nosedive on September 9, 2026. Investors were left clutching their portfolios with bewilderment as shares...

Sabey Data Centers Tests HVO to Cut Emissions

Exploring New Horizons in Data Center Energy A curious tale is unfolding down in Austin, Texas, folks—one where data centers meet renewable energy in a bid to clean up their act. Sabey Data Centers is giving good old-fashioned diesel the boot in favor of hydrotreated vegetable oil (HVO) for backup power. We're not talking about minor tweaks here; this is about testing...

Race for Life Rescue Logs 200 Flights for Shelter Pets

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Everest Group Faces Class Action: Key Deadlines Looming

Everest Group's Legal Quagmire: A Rocky Road Ahead Riding high has its pitfalls. I mean just take a gander at Everest Group, Ltd. (NYSE: EG). The suits and stocks got their knickers in a twist when the company's missteps saw them landing smack dab in the middle of a shareholder class-action lawsuit. It's gloomy days, my friend, especially if you're carrying a portfolio...

Serena's Heart Necklaces: Tennis's Luckiest Jewelry?

You ever thought a piece of jewelry could win a game? Well, that's the buzz stirring in tennis circles these days. The iconic diamond giant, A Diamond Is Forever, dove into the gem-studded histories of some legendary players to crack open the mystery of luckiest jewelry on the court. It turns out Serena Williams takes the cake—with her heart necklaces scoring the...